SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-055004
Filing Date
2020-05-01
Accepted
2020-05-01 08:30:51
Documents
4
Period of Report
2020-04-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a20-18269_18k.htm 8-K 43188
2 EX-10.1 a20-18269_1ex10d1.htm EX-10.1 63912
3 EX-99.1 a20-18269_1ex99d1.htm EX-99.1 10553
4 GRAPHIC g182691mmi001.jpg GRAPHIC 2707
  Complete submission text file 0001104659-20-055004.txt   122879
Mailing Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008
Business Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008 6509345200
VIVUS INC (Filer) CIK: 0000881524 (see all company filings)

IRS No.: 943136179 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33389 | Film No.: 20838511
SIC: 2834 Pharmaceutical Preparations